{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T11:31:07Z","timestamp":1707651067719},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,4]]},"DOI":"10.7759\/cureus.53578","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T01:19:55Z","timestamp":1707095995000},"source":"Crossref","is-referenced-by-count":0,"title":["Idiopathic Pulmonary Fibrosis Comorbid With Mediastinal Small Cell Carcinoma: A Clinical Dilemma"],"prefix":"10.7759","author":[{"given":"Muhammad Hassan","family":"Shakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Abdul Basit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barun K","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muhammad Hussain","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taibah","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Asim","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi G","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, et al.. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022, 33:115-54. 10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis WD","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015, 10:1240-2. 10.1097\/JTO.0000000000000663","journal-title":"J Thorac Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Ganti AK","year":"2021","unstructured":"Ganti AK, Loo BW, Bassetti M, et al.. Small cell lung cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:1441-64. 10.6004\/jnccn.2021.0058","journal-title":"J Natl Compr Canc Netw"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson AG","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, et al.. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022, 17:362-87. 10.1016\/j.jtho.2021.11.003","journal-title":"J Thorac Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.5757","article-title":"Extrapulmonary small cell carcinoma: a pictorial review","volume":"197","author":"Howard S","year":"2011","unstructured":"Howard S, O'Regan K, Jagannathan J, Krajewski K, Giardino A, Ramaiya N. Extrapulmonary small cell carcinoma: a pictorial review. Am J Roentgenol. 2011, 197:W392-8. 10.2214\/AJR.10.5757","journal-title":"Am J Roentgenol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.04.017","article-title":"Extrapulmonary small cell carcinoma: prognostic factors, patterns of care, and overall survival","volume":"46","author":"Mandish SF","year":"2020","unstructured":"Mandish SF, Gaskins JT, Yusuf MB, Little BP, Dunlap NE. Extrapulmonary small cell carcinoma: prognostic factors, patterns of care, and overall survival. Eur J Surg Oncol. 2020, 46:1596-604. 10.1016\/j.ejso.2020.04.017","journal-title":"Eur J Surg Oncol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis WD","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al.. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013, 188:733-48.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ers\/JRS\/Alat clinical practice guideline","volume":"205","author":"Raghu G","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, et al.. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ers\/JRS\/Alat clinical practice guideline. Am J Respir Crit Care Med. 2022, 205:e18-47.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi L","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, et al.. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014, 370:2071-82.","journal-title":"N Engl J Med"},{"key":"ref10","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King TE Jr","year":"2014","unstructured":"King TE Jr, Bradford WZ, Castro-Bernardini S, et al.. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014, 370:2083-92.","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03187-2021","article-title":"Progressive pulmonary fibrosis: an expert group consensus statement","volume":"61","author":"Rajan SK","year":"2023","unstructured":"Rajan SK, Cottin V, Dhar R, et al.. Progressive pulmonary fibrosis: an expert group consensus statement. Eur Respir J. 2023, 61:2103187.","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-015-1398-4","article-title":"Mediastinal small cell carcinoma: a unique clinical entity?","volume":"18","author":"Dai W","year":"2016","unstructured":"Dai W, Liu M, Zhuang X, Li Q, Wang D. Mediastinal small cell carcinoma: a unique clinical entity?. Clin Transl Oncol. 2016, 18:515-20. 10.1007\/s12094-015-1398-4","journal-title":"Clin Transl Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2016.58505","article-title":"Mediastinum primary small cell neuroendocrine carcinoma","volume":"20","author":"Wang HL","year":"2016","unstructured":"Wang HL, Sun ZG, Xiao W, Zhu LM. Mediastinum primary small cell neuroendocrine carcinoma. Contemp Oncol (Pozn). 2016, 20:86-90. 10.5114\/wo.2016.58505","journal-title":"Contemp Oncol (Pozn)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4873","article-title":"Primary mediastinal small cell neuroendocrine carcinoma presenting with superior vena cava syndrome","volume":"11","author":"Costanzo LR","year":"2019","unstructured":"Costanzo LR, Kewan T, Kerwin K, Daw H. Primary mediastinal small cell neuroendocrine carcinoma presenting with superior vena cava syndrome. Cureus. 2019, 11:e4873. 10.7759\/cureus.4873","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29070401","article-title":"Small cell lung cancer in the course of idiopathic pulmonary fibrosis-case report and literature review","volume":"29","author":"Grodkiewicz M","year":"2022","unstructured":"Grodkiewicz M, Koziel P, Chmielewska I, Korbel MA, Milanowski J. Small cell lung cancer in the course of idiopathic pulmonary fibrosis-case report and literature review. Curr Oncol. 2022, 29:5077-83. 10.3390\/curroncol29070401","journal-title":"Curr Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211305-idiopathic-pulmonary-fibrosis-comorbid-with-mediastinal-small-cell-carcinoma-a-clinical-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:17:57Z","timestamp":1707509877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211305-idiopathic-pulmonary-fibrosis-comorbid-with-mediastinal-small-cell-carcinoma-a-clinical-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.53578","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,4]]}}}